drugset / Trial / NCT05548426

Linezolid for Syphilis Pilot Study

NCT05548426

Phase 2 Active not recruiting 24 enrolled University of Southern California
RandomizedParallel-groupOpen-labelTreatment

Summary

The study aims to evaluate the efficacy of linezolid for the treatment of syphilis.

Timeline

Start
2023-09-28
Primary completion
2026-08
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzathine Penicillin G Unknown 2.4 iu Intramuscular
Subject Linezolid Other / unclassified 600 mg Oral

Indications